Volume 11,Issue 6
Preliminary Clinical Investigation on Social Anxiety and Quality of Life in Patients with Facial Psoriasis Vulgaris
Objective: To investigate the psychological status and quality of life in patients with psoriasis involving the facial region, and to further analyze the associated influencing factors. Methods: A total of 60 patients with facial psoriasis vulgaris who had complete clinical data and demonstrated high compliance were enrolled as the investigation group, and 60 patients with non-facial psoriasis vulgaris were selected as the control group. The Liebowitz Social Anxiety Scale (LSAS), Hospital Anxiety and Depression Scale (HADS), and Dermatology Life Quality Index (DLQI) were employed to assess psychological disorders and quality of life in both groups. Statistical analyses were subsequently performed. Results: The investigation group exhibited significantly higher levels of social anxiety, depression, and anxiety compared with the control group (P < 0.05), and quality of life was more severely impaired in the investigation group (P < 0.05). No significant correlation was observed between overall disease severity and social anxiety, depression, or anxiety levels in the investigation group (P > 0.05). However, facial disease severity was positively correlated with social anxiety, depression, and anxiety levels (P < 0.05), and negatively correlated with quality of life (P < 0.05). Social anxiety, depression, and anxiety levels were negatively correlated with quality of life (P < 0.05). Conclusion: Patients with psoriasis vulgaris involving the facial area are predisposed to psychological disorders and social avoidance, with significant impairment in work and academic performance, as well as diminished quality of life.
[1] Alpsoy E, Polat M, Fettahlıoğlu-Karaman B, et al., 2017, Internalized Stigma in Psoriasis: A Multicenter Study. Journal of Dermatology, 44(8): 885–891.
[2] Takeshita J, Grewal S, Langan SM, et al., 2017, Psoriasis and Comorbid Diseases: Epidemiology. Journal of the American Academy of Dermatology, 76(3): 377–390.
[3] Arends LR, Nijsten T, Wakkee M, et al., 2014, The Prevalence and Odds of Depressive Symptoms and Clinical Depression in Psoriasis Patients: A Systematic Review and Meta analysis. The Journal of Investigative Dermatology, 134(6): 1542–1551.
[4] Fleming P, Bai J, Pratt M, et al., 2016, The Prevalence of Anxiety in Patients with Psoriasis: A Systematic Review of Observational Studies and Clinical Trials. Journal of the European Academy of Dermatology and Venereology, 31(5): 798–807.
[5] Je YP, Jong HR, Yong BC, et al., 2004, Facial Psoriasis: Comparison of Patients with and without Facial Involvement. Journal of the American Academy of Dermatology, 50(4): 582–584.
[6] Emge TM, Hope DA, 2006, Social Anxiety Disorder. Lancet, 371(2): 119–125.
[7] Stein MB, Stein DJ, 2008, Social Anxiety Disorder. Lancet, 371(9618): 1115–1125.
[8] Alexis O, Shin DB, Jon LT, et al., 2021, Body Surface Area Affected by Psoriasis and the Risk for Psoriatic Arthritis: A Prospective Population based Cohort Study. Rheumatology, 61(5): 1877–1884.
[9] Rosniza SNC, Sharifah, Robinson S, et al., 2016, Clinical Characteristics of Patients with Facial Psoriasis in Malaysia. International Journal of Dermatology, 2016(55): 1092–1095.
[10] Franklin M, 1996, Social Phobia: Diagnosis, Assessment, and Treatment. Clinical Psychology Review, 1996(16): 777–779.
[11] Yildirim FE, Eremet S, Afar FU, et al., 2020, Evaluation of Social Anxiety Levels and Related Factors in Psoriasis Patients: A Controlled, Cross Sectional Study. Noro Psikiyatri Arsivi, 57(2): 148–153.
[12] Li JN, Gao XM, Wang MX, et al., 2011, Effect of Positive Psychotherapy on the Mental Health and Behaviors of Patients with Psoriasis. Chinese Journal of Nursing, 46(7): 669–671.
[13] Bernharo JD, 1983, Facial Sparing in Psoriasis. International Journal of Dermatology, 22(5): 291–292.
[14] van de Kerkhof PC, Murphy GM, Austad J, et al., 2007, Psoriasis of the Face and flexures. Journal of Dermatological Treatment, 18(6): 351–360.
[15] Sampogna F, Picardi A, Chren MM, et al., 2004, Association between Poorer Quality of Life and Psychiatric Morbidity in Patients with Different Dermatological Conditions. Psychosomatic Medicine, 66(4): 620.
[16] He Z, Lu C, Basra MKA, et al., 2011, Psychometric Properties of the Chinese Version of Dermatology Life Quality Index (DLQI) in 851 Chinese Patients with Psoriasis. Journal of the European Academy of Dermatology and Venereology, 27(1): 109–115.
[17] González Parra S, Daudén E, 2019, Psoriasis and Depression: The Role of Inflammation. Actas Dermo Sifiliográficas (English Edition), 110(1): 12–19.
[18] Demircay Z, Seckin D, Senol A, et al., 2008, Patient’s Perspective: An Important Issue not to be Overlooked in Assessing Acne Severity. European Journal of Dermatology, 18(2): 181–184.
[19] Dowlatshahi EA, Wakkee M, Arends LR, et al., 2014, The Prevalence and Odds of Depressive Symptoms and Clinical Depression in Psoriasis Patients: A Systematic Review and Meta analysis. Journal of Investigative Dermatology, 134(6): 1542–1551.
[20] Pollo CF, Miot HA, Matos TDDS, et al., 2021, Prevalence and Factors Associated with Depression and Anxiety in Patients with Psoriasis. Journal of Clinical Nursing, 30(3–4): 572–580.
